Celator Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Celator Pharmaceuticals Ownership

Who owns Celator Pharmaceuticals?

Celator Pharmaceuticals is owned by Jazz Pharmaceuticals. It was acquired on May 31, 2016.

Celator Pharmaceuticals Business Overview

Where is Celator Pharmaceuticals headquartered?

Celator Pharmaceuticals is headquartered in Ewing, New Jersey.

What sector is Celator Pharmaceuticals in?

Celator Pharmaceuticals is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 293 acquisitions of life science companies in 2016, including 32 acquisitions by private equity firms, and 261 by strategics.

Celator Pharmaceuticals, Inc.

200 PrincetonSouth Corporate Center Suite 180,
Ewing, New Jersey 08628
United States,
(609) 243-0123
www.celatorpharma.com

Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company that is transforming the science of combination therapy, and developing products to improve patient outcomes in cancer. Celator's proprietary technology platform, CombiPlex®, enables the rational design and rapid evaluation of optimized combinations of anti-cancer drugs, incorporating traditional chemotherapies as well as molecularly targeted agents to deliver enhanced anti-cancer activity. CombiPlex addresses several fundamental shortcomings of conventional combination regimens, as well as the challenges inherent in combination drug development, by identifying the most effective synergistic molar ratio of the drugs being combined in vitro, and fixing this ratio in a nano-scale drug delivery complex to maintain the optimized combination after administration and ensuring exposure of this ratio to the tumor.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.